Clinical Trials

Study Title:
A Safety Run-In and Phase II Study Evaluating the Efficacy, Safety, and Impact on the Tumor Microenvironment of the Combination of Tocilizumab, Atezolizumab, and Fractionated Sterotactic Radiotherapy in Recurrent Glioblastoma

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Alicia Zukas, at zukas@musc.edu. Study Coordinator, Eva Newman, at newmanev@musc.edu. Trial opened at the following institutions: Medical University of South Carolina